瘤学临床试验中的心血管安全:JACC:心脏瘤学初步课件
Marc P Bonaca1, Ninian N Lang2, Alice Chen3
1CPC Clinical Research, Cardiology & Vascular medicine, University of Colorado Anschutz Medical School, Aurora, Colorado, USA.
JACC. CardioOncology
|February 19, 2025
概括
新型癌症治疗改善了结果,但可能导致心血管毒性. 本书建议改进在瘤学试验中检测和报告这些不良事件的方法.
科学领域:
- 心血管研究的心血管研究.
- 在瘤学瘤学.
- 临床试验的安全性
背景情况:
- 新型癌症疗法提供了更好的结果,但存在心血管毒性风险.
- 目前的临床试验安全评估在检测心血管风险方面存在局限性.
- 需要改进的方法来提高心血管安全评估的力量和特异性.
研究的目的:
- 为改善瘤学试验中心血管安全信号的收集和报告提供建议.
- 增强对与癌症疗法相关的潜在心血管毒性的理解.
主要方法:
- 召开了一个利益相关者智库,包括学术界,工业界和监管机构的代表.
- 组建了两个工作组:一个是关于对不良事件的共识定义,另一个是关于心血管事件确定和裁决方法.
主要成果:
- 智囊团的重点是改进心血管疾病定义的不良事件共同术语标准 (CTCAE).
- 考虑了在癌症试验中确定和判断心血管事件的方法.
结论:
- 改善心血管安全数据的收集和报告对于瘤学试验至关重要.
- 标准化定义和确定方法将提高对癌症治疗相关心血管毒性的理解和管理.
相关概念视频
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
82
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
82
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K


